FY2025 · ended Dec 31, 2025 · Revenue $71,000, -97.6% YoY · Filed Mar 27, 2026
PAVmed Inc. (PAVM) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $71,000 and net income of $401,000. Free cash flow was -$5.2 million. As of Jun 30, 2026 it held $3.8 million in cash and investments and $2.0 million in total debt.
Revenue (TTM)
$112,000
-89.0% vs year-ago TTM
Net income (TTM)
$-12.09M
-116.6% vs year-ago TTM
Operating cash flow (TTM)
$-7.73M
+33.1% vs year-ago TTM
Free cash flow (TTM)
$-7.78M
+32.8% vs year-ago TTM
EPS (TTM)
$-11.97
+76.7% vs year-ago TTM
Dividend per share
None
Shares outstanding
6.38M
-62.0% vs prior year
Net cash
$1.82M
as of Jun 30, 2026
Operating margin
-23842.0%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- PAVM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1624326
- Former names
- PAXmed Inc. (until Mar 26, 2015)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $71,000 | $3.0M | $2.5M | $377,000 | $500,000 |
| Operating income | -$21.8M | -$44.5M | -$68.8M | -$91.1M | -$54.4M |
| Net income | $401,000 | $39.8M | -$64.2M | -$89.0M | -$50.3M |
| Diluted EPS | -$5.63 | $14.90 | -$9.16 | — | — |
| Operating cash flow | -$5.2M | -$33.6M | -$52.0M | -$71.0M | -$40.6M |
| Free cash flow | -$5.2M | -$33.6M | -$52.3M | -$72.5M | -$42.1M |
| Total assets | $38.8M | $30.7M | $33.1M | $54.0M | $87.0M |
| Total liabilities | $16.5M | $37.7M | $57.1M | $43.0M | $7.6M |
| Stockholders' equity | $34.0M | -$2.5M | -$53.8M | -$9.7M | $61.7M |
| Cash and investments | $1.5M | $1.2M | $19.6M | $39.7M | $77.3M |
| Total debt | $2.2M | $2.8M | $4.5M | $3.0M | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Change to shareholder rights
|
Oct 22, 2026 | Oct 21, 2026 |
| 8-K |
Current report
Material agreement
|
Sep 10, 2026 | Sep 9, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 14, 2026 | Aug 14, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 24, 2026 | Jun 24, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 15, 2026 | May 15, 2026 |
All 691 PAVmed Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.